Patents, biosimilars and trademarks – another triangle? IAM (registration) (blog) Although Roche was taking steps to use Emcure Pharmaceuticals in India "to produce its innovative biologics in India" and to reduce the price for cancer drugs trastuzumab (Herceptin) and rituximab (MabThera), in a surprising but strategic move, Roche ... |
